Healthcare ❯ Pharmaceuticals ❯ Drug Development ❯ Weight Loss Drugs

GLP-1 Medications

Yahoo Finance Highlights Merck and Bristol Myers as Value Plays Outside the GLP-1 Surge

Eli Lilly trades near a 50 P/E with its two GLP-1 drugs already supplying more than half of revenue.

WHO Endorses Long-Term GLP-1 Use for Obesity as Indian Ruling Opens Production and Safety Alerts Expand